John L. Higgins, Chief Executive Officer at LIGAND PHARMACEUTICALS INC (LGND), sold 97,441 shares at $182.00 ($16.4M) on 2021-01-27, disclosed to the SEC on 2021-01-27.
Open-market sale of $16.4M LGND by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $156.01 | 2,845 | $444K | 2.7% |
| 2 | $156.01 | 4,596 | $717K | 4.4% |
| 3 | $159.00 | 50,000 | $8.0M | 48.5% |
| 4 | $182.00 | 40,000 | $7.3M | 44.4% |
| Total | $168.21 avg | 97,441 | $16.4M | 100% |
| Filing → |
| OABI | BUY | 2025-03-21 | $9K | — | Filing → |
| OABI | BUY | 2025-03-20 | $591K | — | Filing → |
| TECH | SELL | 2024-05-16 | $335K | — | Filing → |